FibroGen Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (35)

Latest Posts

About This Stock More About This Stock
Mizuho Downgrades FibroGen To Neutral On 'Higher Risk And Uncertainty'
Article By: The Fly
Wednesday, April 7, 2021 9:44 AM EDT
Mizuho analyst Difei Yang downgraded FibroGen to Neutral from Buy with a price target of $29, down from $72.
In this article: FGEN
Week In Review: Shanghai Industrial To Start $7.3 Billion Biomedical Fund In 2019
Article By: ChinaBio® Today
Saturday, December 29, 2018 4:08 PM EDT
Shanghai Industrial Investment, a state-owned conglomerate, plans to launch a $7.3 billion equity fund for China biopharma investments. The company plans to begin raising $1.5 billion in January for the fund's first tranche.
In this article: AZN, LLY, FGEN
5 Strong Stocks Analysts Are Upgrading Now
Article By: TipRanks
Wednesday, May 23, 2018 2:25 PM EDT
Why is the sentiment now shifting for these five stocks (FGEN, LRCX, ENR, FB and CACI)? Could it be that the market is looking more optimistic?
In this article: CACI, ENR, LRCX, FB, FGEN
Week In Review: WuXi AppTec Acquires US-Global Clinical CRO
Article By: ChinaBio® Today
Saturday, October 21, 2017 5:25 PM EDT
WuXi AppTec, China's largest CRO/CMO, will acquire a global clinical-stage contract research company, ResearchPoint Global, of Austin,Texas. WuXi said the acquisition would extend its CRO network around the world.
In this article: AZN, HCM, RVX, FGEN
FibroGen, Inc. Shares Shoot Up On Positive Results From Phase 2 Study Of Pamrevlumab
Article By: TickerTV
Tuesday, August 8, 2017 10:46 AM EDT
FGEN opened trading yesterday at $34.90 which was down from the previous day’s trading close of $35.00. FGEN closed trading yesterday at $33.40 and spiked up after hours to $53.95, equivalent to a 62% increase from the closing price.
In this article: FGEN

Latest Tweets for $FGEN

No tweets yet!